|
|
| G
|
Abcc9
|
ATP binding cassette subfamily C member 9
|
multiple interactions
|
ISO
|
Adenosine Monophosphate inhibits the reaction [Adenosine Triphosphate results in decreased activity of [KCNJ11 protein binds to ABCC9 protein]]; Creatine metabolite inhibits the reaction [Adenosine Monophosphate inhibits the reaction [Adenosine Triphosphate results in decreased activity of [KCNJ11 protein binds to ABCC9 protein]]]
|
CTD |
PMID:11390963 |
|
NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:177,262,848...177,386,348
|
|
| G
|
Aldh1a1
|
aldehyde dehydrogenase 1 family, member A1
|
multiple interactions
|
ISO
|
[4-dimethylaminocinnamaldehyde co-treated with Adenosine Monophosphate] binds to ALDH1A1 protein
|
CTD |
PMID:10609638 |
|
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
|
|
| G
|
Ercc6
|
ERCC excision repair 6, chromatin remodeling factor
|
increases abundance
|
ISO
|
ERCC6 gene mutant form results in increased abundance of Adenosine Monophosphate
|
CTD |
PMID:25440059 |
|
NCBI chr16:7,771,311...7,841,895
Ensembl chr16:7,771,581...7,841,895
|
|
| G
|
H2ax
|
H2A.X variant histone
|
multiple interactions
|
ISO
|
Adenosine Monophosphate promotes the reaction [Cesium-137 results in increased expression of and affects the localization of H2AX protein modified form]
|
CTD |
PMID:32941855 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Kcnj11
|
potassium inwardly-rectifying channel, subfamily J, member 11
|
multiple interactions
|
ISO
|
Adenosine Monophosphate inhibits the reaction [Adenosine Triphosphate results in decreased activity of [KCNJ11 protein binds to ABCC9 protein]]; Creatine metabolite inhibits the reaction [Adenosine Monophosphate inhibits the reaction [Adenosine Triphosphate results in decreased activity of [KCNJ11 protein binds to ABCC9 protein]]]
|
CTD |
PMID:11390963 |
|
NCBI chr 1:105,727,473...105,731,167
Ensembl chr 1:105,727,570...105,731,169
|
|
| G
|
Nudt11
|
nudix hydrolase 11
|
multiple interactions
|
ISO
|
[NUDT11 protein results in increased metabolism of diadenosine 5',5''''-P1,P6-hexaphosphate] which results in increased chemical synthesis of Adenosine Monophosphate; [NUDT11 protein results in increased metabolism of P(1),P(5)-di(adenosine-5'-)pentaphosphate] which results in increased chemical synthesis of Adenosine Monophosphate
|
CTD |
PMID:12121577 |
|
NCBI chr X:18,998,587...19,005,208
Ensembl chr X:18,998,461...19,005,208
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
increases expression
|
ISO
|
Adenosine Monophosphate results in increased expression of PPARGC1A mRNA
|
CTD |
PMID:23056435 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Tp53bp1
|
tumor protein p53 binding protein 1
|
multiple interactions
|
ISO
|
Adenosine Monophosphate promotes the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein]
|
CTD |
PMID:32941855 |
|
NCBI chr 3:128,620,320...128,724,716
Ensembl chr 3:128,620,322...128,696,747
|
|
| G
|
Tp73
|
tumor protein p73
|
affects abundance
|
ISO
|
TP73 protein affects the abundance of Adenosine Monophosphate
|
CTD |
PMID:25554796 |
|
NCBI chr 5:169,903,801...169,988,075
Ensembl chr 5:169,903,801...169,963,552
|
|
|
|
| G
|
Cdipt
|
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
|
multiple interactions
|
ISO
|
[delta-hexachlorocyclohexane results in decreased activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Inositol promotes the reaction [CDIPT protein results in increased metabolism of Cytidine Diphosphate Diglycerides]] which results in increased abundance of Cytidine Monophosphate
|
CTD |
PMID:2579070 |
|
NCBI chr 1:191,013,632...191,017,943
Ensembl chr 1:191,013,463...191,017,971
|
|
|
|
| G
|
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2
|
multiple interactions increases abundance
|
ISO
|
Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Flavin Mononucleotide]
|
CTD |
PMID:27469509 |
|
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:143,439,323...143,467,248
|
|
| G
|
Rfk
|
riboflavin kinase
|
increases abundance
|
ISO
|
RFK protein results in increased abundance of Flavin Mononucleotide
|
CTD |
PMID:21308351 |
|
NCBI chr 1:224,226,632...224,234,185
Ensembl chr 1:224,226,628...224,235,698 Ensembl chr X:224,226,628...224,235,698
|
|
| G
|
Slc52a3
|
solute carrier family 52 member 3
|
multiple interactions
|
EXP
|
Flavin Mononucleotide inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]
|
CTD |
PMID:19122205 |
|
NCBI chr 3:160,959,233...160,976,170
Ensembl chr 3:160,965,302...160,974,692
|
|
|
|
| G
|
Fut8
|
fucosyltransferase 8
|
decreases activity
|
ISO
|
Guanosine Monophosphate results in decreased activity of FUT8 protein
|
CTD |
PMID:12770769 |
|
NCBI chr 6:101,682,354...101,909,784
Ensembl chr 6:101,683,007...101,909,775
|
|
| G
|
Gmds
|
GDP-mannose 4, 6-dehydratase
|
affects binding
|
ISO
|
Guanosine Monophosphate binds to GMDS protein
|
CTD |
PMID:25526675 |
|
NCBI chr17:32,304,029...32,830,708
Ensembl chr17:32,304,056...32,830,706
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
multiple interactions
|
ISO
|
[NR1I2 protein affects the susceptibility to Pregnenolone Carbonitrile] which affects the abundance of Guanosine Monophosphate
|
CTD |
PMID:38971454 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
|
|
| G
|
App
|
amyloid beta precursor protein
|
multiple interactions increases abundance
|
ISO
|
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Inosine Monophosphate; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Inosine Monophosphate] PF-06840003 inhibits the reaction [APP protein mutant form results in increased abundance of Inosine Monophosphate]
|
CTD |
PMID:39172838 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
EXP
|
[Inosine Monophosphate co-treated with potassium oxonate] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; Inosine Monophosphate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; SCH 442416 inhibits the reaction [Inosine Monophosphate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]]
|
CTD |
PMID:20868668 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Impdh2
|
inosine monophosphate dehydrogenase 2
|
affects binding multiple interactions
|
ISO
|
Inosine Monophosphate binds to IMPDH2 protein berberrubine inhibits the reaction [Inosine Monophosphate binds to IMPDH2 protein]
|
CTD |
PMID:37871880 |
|
NCBI chr 8:118,135,204...118,139,892
Ensembl chr 8:118,135,262...118,139,873
|
|
| G
|
Mapt
|
microtubule-associated protein tau
|
multiple interactions affects abundance
|
ISO
|
PF-06840003 affects the reaction [MAPT protein mutant form affects the abundance of Inosine Monophosphate]
|
CTD |
PMID:39172838 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
| G
|
Mpo
|
myeloperoxidase
|
multiple interactions
|
EXP
|
[potassium oxonate co-treated with Inosine Monophosphate] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Inosine Monophosphate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; SCH 442416 inhibits the reaction [Inosine Monophosphate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]]
|
CTD |
PMID:20868668 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Psen1
|
presenilin 1
|
multiple interactions
|
ISO
|
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Inosine Monophosphate; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Inosine Monophosphate]
|
CTD |
PMID:39172838 |
|
NCBI chr 6:109,054,160...109,106,191
Ensembl chr 6:109,060,352...109,106,189
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
EXP
|
[Inosine Monophosphate co-treated with potassium oxonate] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Inosine Monophosphate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; SCH 442416 inhibits the reaction [Inosine Monophosphate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]]
|
CTD |
PMID:20868668 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tp73
|
tumor protein p73
|
affects abundance
|
ISO
|
TP73 protein affects the abundance of Inosine Monophosphate
|
CTD |
PMID:25554796 |
|
NCBI chr 5:169,903,801...169,988,075
Ensembl chr 5:169,903,801...169,963,552
|
|
|
|
| G
|
Bsg
|
basigin
|
decreases expression
|
ISO
|
Uridine Monophosphate results in decreased expression of BSG protein
|
CTD |
PMID:36574092 |
|
NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:10,643,789...10,651,005
|
|